tretinoin

(redirected from Retin-A Micro)
Also found in: Medical.

tret·i·noin

 (trĕt′ĭ-noin′)
n.
An isomer of retinoic acid used topically to treat acne and to mitigate fine facial wrinkling and orally to treat one form of leukemia.

tretinoin

(trəˈtɪnəʊɪn)
n
(Pharmacology) pharmacol a synthetic form of vitamin A used as a drug to treat certain skin conditions and a type of leukemia

tre•tin•o•in

(trəˈtɪn oʊ ɪn)
n.
a drug chemically related to vitamin A, used as a topical ointment to treat skin disorders, esp. acne.
[1960–65; t(ri-) + retino- (< Greek rhētinē resin) + -in1]
Translations

tretinoin

n tretinoína
References in periodicals archive ?
NYSE: VRX and TSX: VRX) announced today that it has received approval from the Food and Drug Administration (FDA) for its Supplemental New Drug Application (sNDA) for Retin-A Micro (tretinoin) Gel microsphere 0.
A national survey conducted on behalf of Retin-A Micro Pump has found that acne can negatively impact many aspects of an adult's life--professional, academic, physical and social--and a lack of knowledge may be preventing or hindering appropriate treatment options.
The Company recorded a gain on the sale of its interests in royalties from sales of Retin-A Micro and Carac of $23,421,000 in the first quarter of 2006.
The safety of the Microsponge systems has been well-established and they are used in several over-the-counter drug and skin care products besides the two prescription products, Retin-A Micro and the new 5-FU product.
In February 1997, Advanced Polymer received FDA approval for the first product covered by this agreement, Microsponge-entrapped tretinoin, now marketed by Ortho Dermatological under the name Retin-A Micro.
First quarter royalties on sales of Carac and Retin-A Micro grew by 18% and 7%, respectively.
Ortho Dermatological, a member of the Johnson & Johnson family of companies, is Advanced Polymer's marketing partner and rapidly launched Retin-A Micro nationwide.
Fourth quarter royalties on sales of Retin-A Micro and Carac grew by 10% and 18%, respectively.
RETIN-A MICRO is indicated for the topical treatment of acne vulgaris.
Quantum, recently named "Agency of the Year" by DTC Perspectives magazine, received the Silver Award in the "Best Branded Television" and "Best Radio Campaign" categories for its work on consumer campaigns for Crestor, a cholesterol treatment, and Retin-A Micro, a topical acne treatment, respectively.
Crestor, a cholesterol treatment, received a Bronze Award in the "New Brand of the Year" category, and Retin-A Micro, a topical acne treatment, was awarded the Bronze in the "Brand of the Year Over $15 Million in Spending" category.